Literature DB >> 6781881

The influence of cultivation on (pro-)insulin biosynthesis and secretion of isolated pancreatic islets of C57BL-mice, long-term treated with glibenclamide in vivo.

B Wilke, B Ziegler, S Schmidt, P Woltanski, H Zühlke.   

Abstract

Long-term treatment of C57Bl/KsJ and C57Bl/6J mice with glibenclamide in vivo caused a diminished response of insulin to high glucose concentrations (20 mmol/l). Islets of those mice were investigated to answer the question whether it is possible to overcome this diminution of glucose sensitivity by cultivation in presence of high glucose (20 mmol/l). The insulin release of islets of glibenclamide treated mice was significantly lowered also in the first 48 h of cultivation. In the following short-term incubation (2 h) no differences in the glucose stimulated insulin secretion could be seen. The second cultivation period (48-96 h) confirmed these results. Both groups of islets (controls and glibenclamide treated) reached comparable values in insulin release. Cultivation of islets of glibenclamide treated mice in presence of 20 mmol/l glucose for at least 2 days led to a restoration of the glucose sensitivity of insulin release. Insulin biosynthesis, judged by measuring 3H-leucine incorporation into (pro-)insulin, was largely unaffected. In all experimental conditions the insulin content was comparable to that of controls.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6781881

Source DB:  PubMed          Journal:  Endokrinologie        ISSN: 0013-7251


  2 in total

1.  Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content.

Authors:  M Anello; P Gilon; J C Henquin
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

2.  Syngeneic transplantation of rat pancreatic islets into the spleen. Light and electron microscopical findings.

Authors:  F Wohlrab; B Wilke; S Schmidt; L Cossel
Journal:  Int J Pancreatol       Date:  1988 Jan-Feb
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.